sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Updates on Stakes in Mural Oncology
The Vanguard Group, Inc. has filed a disclosure under Rule 8.3 of the Irish Takeover Panel Act regarding its interests in Mural Oncology plc. As of August 7, 2025, Vanguard holds 772,403 ordinary shares, representing 4.47% of Mural Oncology's relevant securities. Details of the securities dealings reveal a purchase of 80 shares and a sale of 16 shares, each at a price of 1.68 USD.
The filing indicates no involvement in cash-settled or stock-settled derivatives and confirms no additional agreements or inducements related to dealing in relevant securities. No new securities transactions or derivative arrangements affecting voting rights have been reported. This submission forms part of regulatory requirements for transparency in securities dealings related to takeover activities in Ireland.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.